Original Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2012; 18(35): 4875-4884
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4875
Figure 6
Figure 6 Receptor of advanced glycation end-products mRNA level of the jejunal segment in the different groups. bP < 0.01 vs DM group. M: Ladder marker; 1, 3, 5, 7: β-actin; 2, 4, 6, 8: RAGE; 1, 2: Control; 3, 4: DM; 5, 6: T1; 7, 8: T2. DM: Diabetic control; T1: High dose; T2: Low dose; RAGE: Receptor of advanced glycation end-products.